Hepatitis: Drugs

Department of Health written question – answered on 27th April 2016.

Alert me about debates like this

Photo of Lord Mancroft Lord Mancroft Conservative

To ask Her Majesty’s Government what impact assessment they made of the introduction of CQUIN scheme BI1 Improving HCV Treatment Pathways through ODNs, and whether they will publish a copy of that assessment.

Photo of Lord Prior of Brampton Lord Prior of Brampton The Parliamentary Under-Secretary of State, Department of Health

The National Institute for Health and Care Excellence specifically requires Operational Delivery Networks to prioritise hepatitis C patients on the basis of clinical need, as part of a progressive rollout of treatments over the next five years and the Commissioning for Quality and Innovation scheme (CQUIN) enables and ensures this take place. There is no separate assessment of impact. NHS England recognises that there is a very significant improvement in inequalities as a result of roll-out treatment for hepatitis C.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.